Artivion | CRY - Bénéfice Avant Impôts

Prix De L'Action
35.29
Variation Quotidienne
-1.10 -3.02%
Mensuellement
-8.46%
Annuel
45.53%
Q1 Prévisions
35.04




Bénéfice Avant Impôts Changement Date
Abbott USD 2.36B 178M 2025-12
Accuray USD 3.23M 6.56M 2024-12
AngioDynamics USD -6.4M 5.03M 2025-09
Artivion USD 11.4M 7.84M 2025-12
AtriCure USD 2.36M 2.45M 2025-12
Baxter International USD 121M 12M 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 938M 3M 2025-09
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Inogen USD -6.06M 467K 2024-09
Integra LifeSciences USD -6.82M 524.13M 2025-09
J&J USD 4.97B 2.53B 2025-12
Mesa Laboratories USD -2.22M 6.03M 2024-12
Orthofix International USD -2.19M 20.07M 2025-12
Pfizer USD 3.33B 290M 2025-09
ResMed USD 482.38M 2.51M 2025-09
Stryker USD 1.03B 13M 2025-09
Surmodics USD -7.51M 1.69M 2024-09
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
Terumo JPY 45.38B 578M 2025-12
Trinity Biotech USD -5.06M 10.74M 2025-09